UBE Past Earnings Performance
Past criteria checks 4/6
UBE's earnings have been declining at an average annual rate of -11.7%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 8.3% per year. UBE's return on equity is 5%, and it has net margins of 4.1%.
Key information
-11.7%
Earnings growth rate
-10.6%
EPS growth rate
Chemicals Industry Growth | 12.4% |
Revenue growth rate | -8.3% |
Return on equity | 5.0% |
Net Margin | 4.1% |
Next Earnings Update | 05 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How UBE makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 493,197 | 20,280 | 56,424 | 10,017 |
30 Jun 24 | 474,402 | 30,130 | 65,699 | 0 |
31 Mar 24 | 468,237 | 28,981 | 54,238 | 10,017 |
31 Dec 23 | 459,291 | 14,095 | 54,281 | 10,165 |
30 Sep 23 | 468,036 | 2,354 | 57,659 | 10,165 |
30 Jun 23 | 487,779 | -9,089 | 56,432 | 10,165 |
31 Mar 23 | 494,738 | -7,006 | 56,149 | 10,165 |
31 Dec 22 | 547,036 | 5,246 | 60,772 | 11,462 |
30 Sep 22 | 593,361 | 14,613 | 63,535 | 11,462 |
30 Jun 22 | 625,154 | 25,483 | 68,223 | 11,462 |
31 Mar 22 | 655,265 | 24,500 | 72,419 | 11,462 |
31 Dec 21 | 651,560 | 32,062 | 70,936 | 11,034 |
30 Sep 21 | 640,561 | 32,210 | 69,352 | 11,034 |
30 Jun 21 | 624,071 | 29,022 | 68,452 | 11,034 |
31 Mar 21 | 613,889 | 22,936 | 67,626 | 11,034 |
31 Dec 20 | 608,977 | 16,773 | 66,629 | 12,137 |
30 Sep 20 | 612,843 | 12,458 | 68,472 | 12,137 |
30 Jun 20 | 638,942 | 17,104 | 69,981 | 12,137 |
31 Mar 20 | 667,892 | 22,976 | 72,024 | 12,137 |
31 Dec 19 | 687,556 | 24,830 | 73,678 | 11,783 |
30 Sep 19 | 716,951 | 30,937 | 74,081 | 11,783 |
30 Jun 19 | 726,137 | 30,116 | 73,878 | 11,783 |
31 Mar 19 | 730,157 | 32,499 | 73,522 | 11,783 |
31 Dec 18 | 728,986 | 27,855 | 72,987 | 13,016 |
30 Sep 18 | 716,683 | 28,251 | 72,651 | 13,016 |
30 Jun 18 | 705,041 | 32,028 | 72,350 | 13,016 |
31 Mar 18 | 695,574 | 31,680 | 72,208 | 13,016 |
31 Dec 17 | 683,710 | 35,783 | 70,935 | 13,502 |
30 Sep 17 | 662,651 | 32,860 | 69,743 | 13,502 |
30 Jun 17 | 638,084 | 30,584 | 68,450 | 13,502 |
31 Mar 17 | 616,563 | 24,185 | 67,459 | 13,502 |
31 Dec 16 | 599,333 | 14,955 | 65,714 | 13,639 |
30 Sep 16 | 599,558 | 12,504 | 65,386 | 13,639 |
30 Jun 16 | 618,462 | 12,901 | 66,406 | 13,639 |
31 Mar 16 | 641,750 | 19,111 | 66,743 | 13,639 |
31 Dec 15 | 650,309 | 28,748 | 66,515 | 13,766 |
30 Sep 15 | 657,296 | 28,317 | 66,108 | 13,766 |
30 Jun 15 | 654,570 | 22,232 | 65,539 | 13,766 |
31 Mar 15 | 641,759 | 14,649 | 64,863 | 13,766 |
31 Dec 14 | 647,588 | 8,133 | 78,475 | 0 |
30 Sep 14 | 647,435 | 5,991 | 79,095 | 0 |
30 Jun 14 | 645,635 | 11,698 | 78,763 | 0 |
31 Mar 14 | 650,510 | 12,623 | 79,757 | 0 |
31 Dec 13 | 638,261 | 5,312 | 79,914 | 0 |
Quality Earnings: UBE has high quality earnings.
Growing Profit Margin: UBE's current net profit margins (4.1%) are higher than last year (0.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: UBE's earnings have declined by 11.7% per year over the past 5 years.
Accelerating Growth: UBE's earnings growth over the past year (761.5%) exceeds its 5-year average (-11.7% per year).
Earnings vs Industry: UBE earnings growth over the past year (761.5%) exceeded the Chemicals industry 5%.
Return on Equity
High ROE: UBE's Return on Equity (5%) is considered low.